Klavocin Dt

Amoxicillin, the active ingredient in Klavocin Dt, is a penicillin (beta‑lactam) antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections, including respiratory, sinus, ear, skin, and urinary tract infections, in adults and children as prescribed, and is commonly prescribed.

GNH USA supplies Klavocin Dt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this essential antibacterial agent.

Klavocin Dt is used to treat bacterial infections of the respiratory, ear, skin, and urinary systems.

Respiratory tract infections: eradicates causative bacteria and helps relieve cough and sputum production. Sinusitis: reduces sinus inflammation by eliminating bacterial pathogens. Otitis media: clears middle‑ear infection and improves hearing discomfort. Skin and soft‑tissue infections: treats cellulitis, abscesses and wound infections. Urinary tract infections: eliminates uropathogens and resolves dysuria and frequency.

Adverse reactions to Klavocin Dt may vary in frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Rash - Headache

Serious or Rare Side Effects: - Anaphylaxis (severe allergic reaction) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Clostridioides difficile‑associated colitis - Elevated liver enzymes or hepatitis

Before prescribing Klavocin Dt, clinicians should consider the following precautions. Assess allergy history: confirm no known hypersensitivity to penicillins or β‑lactamase inhibitors. Renal function: adjust dosage in patients with impaired renal clearance. Hepatic function: monitor liver enzymes in patients with pre‑existing liver disease. Use in pregnancy: weigh potential benefits against risks and consult an obstetrician. Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Klavocin Dt may interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid): - Probenecid: can increase amoxicillin plasma concentrations, raising toxicity risk. - Methotrexate: reduced clearance may lead to severe toxicity. - Oral contraceptives: efficacy may be decreased, increasing pregnancy risk.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect; monitor INR. - Allopurinol: combined use can increase rash incidence. - Ciprofloxacin: may disrupt gut flora and heighten diarrhea risk.